Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconINSMInsmed$33.42bnn/an/a
us flag iconIQVIqvia Holdings$28.09bn19.98n/a
us flag iconBNTXBioNTech SE$24.00bnn/an/a
us flag iconEXASExact Sciences$20.03bnn/an/a
us flag iconRVMDRevolution Medicines$19.11bnn/an/a
us flag iconSMMTSummit Therapeutics$15.25bnn/an/a
us flag iconASNDAscendis Pharma A/S$14.83bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$14.25bnn/an/a
us flag iconMEDPMedpace Holdings$14.09bn32.3n/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconIONSIonis Pharmaceuticals$12.42bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$11.92bnn/an/a
us flag iconEXELExelixis$11.50bn15.6n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$9.12bn42.27n/a
us flag iconPRAXPraxis Precision Medicines$8.80bnn/an/a
us flag iconPCVXVaxcyte$8.76bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconTECHBIO-TECHNE$8.69bn47.260.58%